Ignite Creation Date:
2025-12-25 @ 2:47 AM
Ignite Modification Date:
2026-02-25 @ 7:27 PM
Study NCT ID:
NCT00044733
Status:
COMPLETED
Last Update Posted:
2006-05-18
First Post:
2002-09-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study Evaluating Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia After Stem Cell Transplant
Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer